Pfizer scales back vaccine rollout because of supply-chain issues
Pfizer is set to go before the FDA for emergency approval of its COVID vaccine, but there's an issue they have run into.
Pfizer is set to go before the FDA for emergency approval of its COVID vaccine, but there's an issue they have run into.